Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Bernard Naughton

Associate Professor (Pharmacy)
      
Profile Photo

Dr. Bernard Naughton

Associate Professor (Pharmacy)

 BERNARD.NAUGHTON@tcd.ie

 


Research Interests Bernard's research focusses on two themes, Pharmaceutical Regulation and Healthcare Management. More specifically he is interested in behaviours, technology, and regulation concerning the global health issue of substandard and falsified medicine. Regarding healthcare innovation, he is interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. His research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as Social Science and Medicine, BMJ Global Health and Lancet Global Health. He has also contributed to the regulatory affair's professional society, where he has authored several book chapters. Background Bernard is an Associate Professor and interdisciplinary researcher at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin where he is also the Director of the MSc in Pharmaceutical Manufacturing Technology. Prior to this appointment, Bernard was a research fellow at the Saïd Business School, and a member of St Antony's College, at the University of Oxford. Bernard holds a PhD in science and technology in medicine which was jointly supervised by the University of Oxford, Saïd Business School and the Institute of Science and Technology at Keele University. Bernard is a clinical pharmacist by training and has over ten years' experience working with large NHS teaching hospitals. Funders Bernards research has been funded by The University of Oxford, the Norwegian Research Council, the Wellcome Trust, and private technology firms. Other Engagements Bernard is an associate editor for the Sage journal The Journal of Medicine Access, and a Visiting Senior Lecturer in the Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London. Bernard has also consulted for charities, education providers, professional and regulatory bodies, and the pharmaceutical industry.
  Digital Health   Evaluation and Impact Assessment   Health Technology   Healthcare Innovation   ORGANIZATIONAL BARRIERS   Quality, regulatory and GMP areas of pharmaceutical chemistry   Responsible Research and Innovation   STIGMA
Project Title
 Hybrid stigma in the digital research and innovation context
From
To
Summary
This study investigated the effect of Stigma on Innovation in the digital health sector
Funding Agency
Wellcome Trust
Project Title
 The Future of Falsified and Substandard Medicine. Detection: Digital Methods to Track and Authenticate Pharmaceutical Products. A policy case study.
From
2017
To
2018
Summary
Working with the Blavatnik School of Government at the University of Oxford and as part of the Pathways for Prosperity project I contributed a case study regarding digital technologies to address the issue of substandard and falsified medicines in low income countries.
Funding Agency
Bill and Melinda Gates Foundation.
Project Type
Policy Project

Details Date
Associate Editor: Journal of Medicine Access 2021
Associate Editor for the Journal of Medicine Access
Visiting Senior Lecturer, Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London 2021
QP Forum Steering Committee Member 2021
External Examiner for Technological University Dublin 2023
External Examiner South East Technological University 2023
Falsified Medicines Advisory board member for UK Government MHRA (Medicines Healthcare and Regulatory Authority). 2018-2019
Journal reviewer for the Academy of Management
Journal reviewer for Health Services Research
Journal Reviewer for Health Services Research (2022)
Journal reviewer for the Journal of King Saud University
Journal reviewer for the International Journal of Environmental Research and Public Health (Reviewer Board Member)
Reviewer for the MDPI journal Pharmacy
Reviewer for Lancet Oncology
Reviewer for Sustainability
Reviewer for Therapeutic Innovation and Regulatory Science
Editorial Board Member at The Journal of Medicine Access 2017
Regular Journal Reviewer for BMJ Global Health
Principal Consultant. Solfen Healthcare Limited. 2011
Reviewer Board member for The International Journal of Environmental Research and Public Health 2021
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
Details Date From Date To
Royal Pharmaceutical Society of Great Britain 2015 Current
Academy of Management 2019 Current
Regulatory Affairs Professional Society 2021 Current
Murphy N., Garvey E., Naughton B.D., Use of design thinking to develop a benchmarking tool to assess documentation procedures in a hospital pharmacy aseptic compounding unit: a case study, European Journal of Hospital Pharmacy, 2025, Journal Article, PUBLISHED  DOI
Naughton B.D., Planned Behavior in the United Kingdom and Ireland Online Medicine Purchasing Context: Mixed Methods Survey Study, JMIR Formative Research, 9, 2025, Journal Article, PUBLISHED  DOI
Niarchou E, Roberts LH, Naughton BD., What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review., Journal of psychopharmacology (Oxford, England), 38, (2), 2024, p127-136 , Journal Article, PUBLISHED  DOI
Muireann Counihan, Larisa Cervenakova, Dominika Misztela, Maarten Van Baelen, Bernard D. Naughton, Original Research, The Journal of Medicine Access, 2024, Journal Article, PUBLISHED
Counihan M., Cervenakova L., Misztela D., Van Baelen M., D.Naughton B., Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set, Journal of Medicine Access, 8, 2024, Journal Article, PUBLISHED  DOI
Howlett M., Niarchou E., Naughton B.D., The response of the Irish pharmaceutical manufacturing sector to the COVID-19 pandemic with a focus on Lean and JIT, Journal of Medicine Access, 8, 2024, Journal Article, PUBLISHED  DOI
Gill M.J., Naughton B.D., Field M., Shaw S.E., Perceptions of impure innovation: Health professionals" experiences and management of stigmatization when working as digital innovators, Social Science and Medicine, 360, 2024, Journal Article, PUBLISHED  DOI
Naser K., Haq Z., Naughton B.D., The Impact of Climate Change on Health Services in Low- and Middle-Income Countries: A Systematised Review and Thematic Analysis, International Journal of Environmental Research and Public Health, 21, (4), 2024, Review, PUBLISHED  DOI
Melia E., English A., Naughton B.D., The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review, Frontiers in Medicine, 11, 2024, Review, PUBLISHED  DOI
Bernard Naughton, Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation, Journal of Responsible Innovation , 2023, Journal Article, PUBLISHED
  

Page 1 of 4
Bernard D. Naughton, Tatiana Iakovleva, Sue Dopson, Start with the end in mind - Responsible Impact for digital healthcare innovation, Oxford Answers, 2024, Journal Article, PUBLISHED
EN L. Roberts, B.D. Naughton, An analysis of the impact of antidepressant side effects on medication adherence among adults with a diagnosed mental disorder, All Ireland Schools of Pharmacy Conference, 2023, Oral Presentation, PUBLISHED
L Roberts, BD Naughton, E Niarchiou, Patient Perspectives of medicine use, adherence and doctor-patient communication: A Service Evaluation of the "Open Up About Medicines" Campaign, Midlands Health Psychology Network 18th Annual Conference, 26, Online, 2023, Poster, PUBLISHED
Bernard Naughton, Pharmaceutical Serialisation & Traceability; Approaches, Legislation, Challenges & Opportunities , Tackling Illicit Trade in Trinidad and Tobago, Online, July , 2021, British High Commission, Invited Talk, PRESENTED
Bernard Naughton, In a time of pandemic, we need to stamp out quackery, Oxford, UK, 2020, Notes: [https://www.sbs.ox.ac.uk/oxford-answers/time-pandemic-we-need-stamp-out-quackery], Report, PUBLISHED
Bernard Naughton, Counterfeit medicine, illegal substances and Falsified Medicines Directive (FMD), Royal Pharmaceutical Society of Great Britain Science and Research Summit, London, 2019, Royal Pharmaceutical Society of Great Britain, Invited Talk, PRESENTED
Bernard Naughton, West Midlands Chief Pharmacist Symposium, England, Staffordshire, 2018, Invited Talk, PRESENTED
Bernard Naughton, 7th Annual Anti-Counterfeiting and Serialisation Conference, London, 2018, Invited Talk, PRESENTED
Bernard Naughton, 23rd European Association of Hospital Pharmacists Conference, Gothenburg, 2018, Invited Talk, PRESENTED
Bernard Naughton, Fulfilling Patient Needs; A View From The Sharp End, 22nd European Association of Hospital Pharmacists Conference, Cannes, France, March, 2017, European Associate of Hospital Pharmacists, Invited Talk, PRESENTED

  


Page 1 of 2
Award Date
Pharma Education and Training Award at the 2024 Irish Pharma Industry Awards 2024
My research focusses on two themes, 1. Pharmaceutical Regulation and Quality and 2. Healthcare Innovation. More specifically he is interested in estimating the problem as well as behaviour, technology, and regulation concerning substandard and falsified medicine. Regarding healthcare innovation, I am interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. My research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. I have also contributed to the regulatory affair's professional society, where I have authored several book chapters.